235 related articles for article (PubMed ID: 28743435)
1. Editorial overview: Antiviral strategies: Antiviral drug design: creating new ideas against old and new bugs.
Naesens L; Zoulim F
Curr Opin Virol; 2017 Jun; 24():v-vii. PubMed ID: 28743435
[No Abstract] [Full Text] [Related]
2. Editorial overview: antivirals and resistance: advances and challenges ahead.
Menéndez-Arias L; Richman DD
Curr Opin Virol; 2014 Oct; 8():iv-vii. PubMed ID: 25155454
[No Abstract] [Full Text] [Related]
3. Editorial overview: Engineering for viral resistance.
von Brunn A
Curr Opin Virol; 2015 Oct; 14():v-vii. PubMed ID: 26320757
[No Abstract] [Full Text] [Related]
4. Human viral diseases: what is next for antiviral drug discovery?
De Clercq E
Curr Opin Virol; 2012 Oct; 2(5):572-9. PubMed ID: 22846888
[TBL] [Abstract][Full Text] [Related]
5. The program of antiviral agents inhibits virus infection.
Ding YZ; Lv JL; Zhang ZW; Ma XY; Zhang J; Zhang YG
Arch Microbiol; 2018 Aug; 200(6):841-846. PubMed ID: 29846759
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic Potential of Spirooxindoles as Antiviral Agents.
Ye N; Chen H; Wold EA; Shi PY; Zhou J
ACS Infect Dis; 2016 Jun; 2(6):382-92. PubMed ID: 27627626
[TBL] [Abstract][Full Text] [Related]
7. Antiviral strategies. Preface.
Kräusslich HG; Bartenschlager R
Handb Exp Pharmacol; 2009; (189):v-vi. PubMed ID: 19198059
[No Abstract] [Full Text] [Related]
8. What is the antiviral potential of pyrrole-imidazole polyamides?
He G; Bashkin JK
Future Med Chem; 2015; 7(15):1953-5. PubMed ID: 26496156
[No Abstract] [Full Text] [Related]
9. Antiviral Strategies Based on Lethal Mutagenesis and Error Threshold.
Perales C; Domingo E
Curr Top Microbiol Immunol; 2016; 392():323-39. PubMed ID: 26294225
[TBL] [Abstract][Full Text] [Related]
10. Broad-Spectrum Antivirals and Antiviral Drug Combinations.
Oksenych V; Kainov DE
Viruses; 2022 Feb; 14(2):. PubMed ID: 35215894
[TBL] [Abstract][Full Text] [Related]
11. New horizons for antiviral drug discovery from virus-host protein interaction networks.
de Chassey B; Meyniel-Schicklin L; Aublin-Gex A; André P; Lotteau V
Curr Opin Virol; 2012 Oct; 2(5):606-13. PubMed ID: 23025912
[TBL] [Abstract][Full Text] [Related]
12. Facilitating Antiviral Drug Discovery Using Genetic and Evolutionary Knowledge.
Xu X; Zhang QY; Chu XY; Quan Y; Lv BM; Zhang HY
Viruses; 2021 Oct; 13(11):. PubMed ID: 34834924
[TBL] [Abstract][Full Text] [Related]
13. Carbazole Derivatives as Antiviral Agents: An Overview.
Caruso A; Ceramella J; Iacopetta D; Saturnino C; Mauro MV; Bruno R; Aquaro S; Sinicropi MS
Molecules; 2019 May; 24(10):. PubMed ID: 31109016
[No Abstract] [Full Text] [Related]
14. Successes and challenges in the antiviral field.
Shaw ML; Klumpp K
Curr Opin Virol; 2013 Oct; 3(5):483-6. PubMed ID: 24035683
[No Abstract] [Full Text] [Related]
15. Staying ahead of viruses: a never ending task.
Lamarre D; Wainberg MA
Curr Opin Virol; 2012 Oct; 2(5):569-71. PubMed ID: 23025913
[No Abstract] [Full Text] [Related]
16. Nucleic acid-based drugs against emerging zoonotic viruses.
Wong JP
Future Med Chem; 2015; 7(13):1709-19. PubMed ID: 26399689
[TBL] [Abstract][Full Text] [Related]
17. RNA interference & inhibition of viruses.
Gadkari DA
Indian J Med Res; 2005 Mar; 121(3):147-50. PubMed ID: 15802755
[No Abstract] [Full Text] [Related]
18. Application of modified antisense oligonucleotides and siRNAs as antiviral drugs.
Wagner A; Bock CT; Fechner H; Kurreck J
Future Med Chem; 2015; 7(13):1637-42. PubMed ID: 26381598
[No Abstract] [Full Text] [Related]
19. [Mechanisms of the formation of viral resistance to chemotherapeutic preparations].
Chizhov NP
Vopr Virusol; 1985; 30(3):266-79. PubMed ID: 3901520
[No Abstract] [Full Text] [Related]
20. Structural biology in antiviral drug discovery.
Bassetto M; Massarotti A; Coluccia A; Brancale A
Curr Opin Pharmacol; 2016 Oct; 30():116-130. PubMed ID: 27611878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
